Table 1.
Participant Characteristics (N = 19)
| Characteristic | No. (%) |
|---|---|
| Region of the US | |
| Northeast | 5 (26) |
| West | 7 (37) |
| South | 6 (32) |
| Midwest | 1 (5) |
| Practice setting | |
| Community health center | 1 (5) |
| Hospital-based outpatient clinic | 5 (26) |
| Non-hospital group practice | 9 (47) |
| Solo private practice | 1 (5) |
| Other outpatient setting | 3 (16) |
| Type of physician | |
| Internal medicine | 9 (47) |
| Family medicine | 10 (53) |
| Patient population | |
| Adults only | 8 (42) |
| Adults and children ≤18 years | 11 (58) |
| AUD medications prescribed in prior 6 monthsa | |
| Disulfiram | 13 (68) |
| Naltrexone | 17 (90) |
| Acamprosate | 11 (58) |
AUD = alcohol use disorder; US = United States.
a
Participants may be counted more than once (ie, if they prescribed multiple medications). We asked participants what medications they had prescribed for AUD within the last 6 months, and did not probe systematically for use of specific medications.